BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21292343)

  • 1. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
    Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
    Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
    Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
    Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of metalloproteinase gene polymorphisms and lung cancer.
    Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
    J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.
    Teng YH; Liu TH; Tseng HC; Chung TT; Yeh CM; Li YC; Ou YH; Lin LY; Tsai HT; Yang SF
    Head Neck; 2009 Oct; 31(10):1282-8. PubMed ID: 19373784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
    Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
    Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer.
    Razmkhah M; Doroudchi M; Ghayumi SM; Erfani N; Ghaderi A
    Lung Cancer; 2005 Sep; 49(3):311-5. PubMed ID: 15955592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer.
    Ribeiro R; Araújo AP; Coelho A; Catarino R; Pinto D; Araújo A; Calçada C; Lopes C; Medeiros R
    Eur J Cancer; 2006 May; 42(8):1188-93. PubMed ID: 16630717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell derived factor-1 genetic variation at locus 801 in patients with myasthenia gravis.
    Yousefipour GA; Haghshenas MR; Yahyazadeh S; Erfani N
    Iran J Immunol; 2011 Jun; 8(2):90-5. PubMed ID: 21705836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
    Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
    Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
    Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
    Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.
    Cui E; Deng A; Wang X; Wang B; Mao W; Feng X; Hua F
    Biochem Cell Biol; 2011 Jun; 89(3):308-13. PubMed ID: 21619462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.